Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayOct 03, 2017 12:33 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 3, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: CLSN 159.60% – News: Posts final clinical and translational research data from its OVATION Study KOOL 36.39% – News: Obtains U.S. patent covering cell separation method ETRM 14.19% – News: Acquires ReShape Medical, Inc. GEVO 10.05% – News: Expects to supply its renewable ATJ to the Virgin Australia Group EGAN 8.93% – News: Hosting eGain Digital+AI Day on December 5 RMGN 8.58% – News: Launches communication platform Korbyt™ MNGA 5.35% – News: Enters LOI…

Continue Reading

TuesdayOct 03, 2017 12:33 pm

NetworkNewsBreaks – DOJA Cannabis Company (CSE: DOJA) Expands Production Capacity with Building Acquisition in Kelowna

DOJA Cannabis Company (CSE: DOJA) this morning said the courts have approved its offer to acquire a 22,580 sq.ft. building in Kelowna, British Columbia, out of bankruptcy protection. The closing of the acquisition is anticipated to take place on October 27. The company is also building a new facility which, upon completion, will raise DOJA’s corporate cannabis production capacity to more than 5,000 kg per year. “The acquisition is a game changer for DOJA, it allows us to expand our production capacity by almost 8 times, diversify our strain production, integrate a world class extraction lab and leverage the economies…

Continue Reading

TuesdayOct 03, 2017 12:33 pm

NetworkNewsBreaks – Moxian (NASDAQ: MOXC) Cashes in on China’s Growing Cashless Trend

Within the global market, consumer trends are ever tending toward the utilization of mobile devices when making purchases and otherwise connecting with businesses—something seen particularly among Chinese consumers. Well aware of China’s cashless trend, Moxian, Inc. (NASDAQ: MOXC) is cashing in by serving the online-to-offline (O2O) market with its Moxian User App and Business App—both of which feature UnionPay’s payment gateway. An article further discussing this reads: “China has 1.3 billion residents. A large number of them use smartphones, and three-quarters of all online payments are sent through mobile accounts, according to analyst estimates. Spending through mobile payment platforms in…

Continue Reading

TuesdayOct 03, 2017 12:31 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Breakthrough Lipid-Based Delivery System Revolutionizes Delivery of Cannabinoids and More

Pioneering biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed a breakthrough lipid-based system that facilitates more efficient delivery of bioactive compounds—not only enhancing bio-absorption and bioavailability but also improving taste, smell and the onset of action. Lexaria intends to out-license this patented and proprietary technology, and the company has already applied this delivery technology to its line of products, which includes ViPova, Lexaria Energy and TurboCBD. An article further discussing this reads: “Lexaria’s novel technology, DehydraTECH™, ticks all these boxes by infusing the molecules of organically sourced hemp oil, high in cannabidiol (CBD), inside the molecules of…

Continue Reading

TuesdayOct 03, 2017 12:29 pm

NetworkNewsBreaks – India Globalization Capital (NYSE: IGC) Demonstrates Potential in Alzheimer’s Treatment Market

In response to compelling recent data, India Globalization Capital, Inc. (NYSE MKT: IGC) announced it has made a highly significant novel breakthrough in treating Alzheimer’s disease with tetrahydrocannabinol (THC)—an advancement that could potentially bring much-needed relief to Alzheimer’s sufferers. A recent IGC press release (http://nnw.fm/VlXb3) gave an update on in vitro data that has been compiled from genetically engineered cell lines in an Alzheimer’s disease model, demonstrating that, at varying THC concentrations, the aggregation of Aβ protein (the buildup of which has been linked to causing Alzheimer’s) decreases by up to 40 percent. An article further discussing this reads: “IGC…

Continue Reading

TuesdayOct 03, 2017 10:16 am

NetworkNewsBreaks – AppSwarm, Inc. (SWRM) Enters Joint Venture with Estorerunner

Technology development and incubation acceleration company AppSwarm, Inc. (OTC: SWRM) this morning announced a joint venture with “last-mile” delivery company Estorerunner, a nationally franchised on-demand delivery service for local grocery stores and pharmacies. “We are very excited to partner with AppSwarm to utilize its software platform for the management of our delivery and payment process,” Gary Chatman, CEO of Estorerunner, stated in the news release. “The development of this proprietary application will further streamline our business model. Having a real-time tracking system for customers, drivers, and payment processing all in an easy to use app, will have a dramatic impact…

Continue Reading

TuesdayOct 03, 2017 9:51 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Announces Joint Venture with “Yelp of the Cannabis Industry”

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its MoneyTrac Technology, Inc. subsidiary has completed the execution of a joint venture partnership agreement with MediaTechnics Corporation’s (OTC: MEDT) BlazeNow Inc. subsidiary. Referred to as the “Yelp of the cannabis industry” by the New York Daily News, BlazeNow is an advertising and data collection platform focused on connecting cannabis-related businesses with patients and customers through its iOS and Android-based applications and website. Through the newly-announced joint venture, the two companies will develop and deploy marketing strategies aimed at expanding BlazeNow’s foothold in the booming cannabis industry. “The…

Continue Reading

TuesdayOct 03, 2017 9:28 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Announces Filing of Provisional Patent for Cannabinoid-Based Pain Treatment

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the filing of a provisional patent application in the United States for INM-405 and other unique compositions as cannabinoid-based topical therapies for the treatment of pain, marking an important step toward protection of the company’s intellectual and commercial property. “There remains a significant need in the field of analgesia for a product that can treat pain via a topical route of administration, which would reduce systemic exposure and any associated side effects,” Dr. Sazzad Hossain, chief scientific officer of InMed and a co-inventor on the newly-filed…

Continue Reading

MondayOct 02, 2017 11:54 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 2, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ECYT 87.23% – News: In-licenses PSMA-617 from ABX GmbH RIGL 32.28% – News: Provides update from FDA meeting regarding Fostamatinib for ITP QTRH 21.98% – News: Posts financial update on Q3 2017 ATEC 21.02% – News: Names new executive chairman and member of the board SRAX 17.20% – News: Acquires demand-side platform from OpenDSP AMCT 13.98% – News: Names new CFO CPST 9.35% – News: Receives a C1000 Signature Series microturbine order ITUS 8.38%…

Continue Reading

MondayOct 02, 2017 11:53 am

NetworkNewsBreaks – Mizuho Securities Reiterates “Buy” Rating on Aerie Pharmaceuticals, Inc. (NASDAQ: AERI)

Mizuho Securities USA LLC has reiterated its ‘Buy’ rating and price target of $70 on shares of Aerie Pharmaceuticals, Inc.’s (NASDAQ: AERI) stock after a Mizuho analyst spoke with company management regarding recent updates. Aerie’s shares have been weak since the company announced that its FDA advisory committee meeting on Rhopressa is scheduled for October 20. The analyst believes the weak shares represent a buying opportunity for investors. Additionally, the analysts noted that they believe the majority of the discussion at the meeting with the FDA on Rhopressa will be regarding potential side effects rather than efficacy. For more information,…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000